Genenta Science Cash Flow From Operations vs. Shares Outstanding
| GNTA Stock | USD 4.69 0.11 2.29% |
For Genenta Science profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Genenta Science to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Genenta Science SpA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Genenta Science's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Genenta Science SpA over time as well as its relative position and ranking within its peers.
Genenta |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genenta Science. If investors know Genenta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genenta Science listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.51) | Return On Assets (0.26) | Return On Equity (0.43) |
The market value of Genenta Science SpA is measured differently than its book value, which is the value of Genenta that is recorded on the company's balance sheet. Investors also form their own opinion of Genenta Science's value that differs from its market value or its book value, called intrinsic value, which is Genenta Science's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genenta Science's market value can be influenced by many factors that don't directly affect Genenta Science's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genenta Science's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genenta Science is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genenta Science's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Genenta Science SpA Shares Outstanding vs. Cash Flow From Operations Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Genenta Science's current stock value. Our valuation model uses many indicators to compare Genenta Science value to that of its competitors to determine the firm's financial worth. Genenta Science SpA is rated # 4 in cash flow from operations category among its peers. It is rated below average in shares outstanding category among its peers . The current year's Common Stock Shares Outstanding is expected to grow to about 20 M. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genenta Science's earnings, one of the primary drivers of an investment's value.Genenta Shares Outstanding vs. Cash Flow From Operations
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Genenta Science |
| = | (11.21 M) |
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Genenta Science |
| = | 18.29 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Genenta Shares Outstanding Comparison
Genenta Science is currently under evaluation in shares outstanding category among its peers.
Genenta Science Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Genenta Science, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Genenta Science will eventually generate negative long term returns. The profitability progress is the general direction of Genenta Science's change in net profit over the period of time. It can combine multiple indicators of Genenta Science, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 265.8 K | 279.1 K | |
| Net Interest Income | 309.3 K | 324.7 K | |
| Operating Income | -11.7 M | -12.3 M | |
| Net Loss | -11.6 M | -11.1 M | |
| Income Before Tax | -11.6 M | -11.1 M | |
| Total Other Income Expense Net | 87.5 K | 83.1 K | |
| Net Loss | -5 M | -5.3 M | |
| Net Loss | -11.6 M | -11.1 M | |
| Income Tax Expense | 4.00 | 4.20 | |
| Change To Netincome | 935.1 K | 782.9 K | |
| Net Loss | (0.64) | (0.67) | |
| Income Quality | 0.96 | 0.75 | |
| Net Income Per E B T | 0.49 | 0.95 |
Genenta Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Genenta Science. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Genenta Science position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Genenta Science's important profitability drivers and their relationship over time.
Use Genenta Science in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Genenta Science position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genenta Science will appreciate offsetting losses from the drop in the long position's value.Genenta Science Pair Trading
Genenta Science SpA Pair Trading Analysis
The ability to find closely correlated positions to Genenta Science could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Genenta Science when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Genenta Science - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Genenta Science SpA to buy it.
The correlation of Genenta Science is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Genenta Science moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Genenta Science SpA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Genenta Science can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Genenta Science position
In addition to having Genenta Science in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Marketing Thematic Idea Now
Marketing
Companies providing marketing and public relation (PR) services as well as news and media distribution. The Marketing theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marketing Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
To fully project Genenta Science's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Genenta Science SpA at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Genenta Science's income statement, its balance sheet, and the statement of cash flows.